Cargando…
False-positive (111)In-pentetreotide Uptake in Gastritis
(111)In-pentetreotide [(111)In-octreoscan] is the most widely used radiolabeled somatostatin analog for evaluating neuroendocrine tumor overexpression of somatostatin receptors. False-positives studies of somatostatin receptor scintigraphy have been reported and often the cause is unexplained but as...
Autores principales: | Usmani, Sharjeel, Alshammari, Alshaima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131396/ https://www.ncbi.nlm.nih.gov/pubmed/25126002 http://dx.doi.org/10.4103/1450-1147.136699 |
Ejemplares similares
-
Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors
por: Kubota, Kazuo, et al.
Publicado: (2014) -
(111)In-pentetreotide uptake in accessory spleen: A potential pitfall in somatostatin receptor scintigraphy
por: Salihoglu, Yavuz Sami, et al.
Publicado: (2016) -
Chronic Recurrent Multifocal Osteomyelitis in Children: A Multidisciplinary Approach is needed to establish a Diagnosis
por: Alshammari, Alshaima, et al.
Publicado: (2013) -
Sarcoidosis mimicking metastatic carinoid on indium-111 pentetreotide scintigraphy
por: Rafiei, Poyan, et al.
Publicado: (2015) -
Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy
por: Karyagar, Savas, et al.
Publicado: (2008)